Akebia does not expect to initiate VALOR clinical trial following Type C meeting feedback from U.S. FDACAMBRIDGE, Mass., Oct.
Drinking green tea is safe for most people but consuming large amounts may raise the risk of iron deficiency anemia, liver ...
New professional guidance to the nation's pediatricians advises against using a drug in children with autism that many families are clamoring for after it was hyped by federal officials.
Akebia Therapeutics has scrapped plans for trial that would have potentially led to an expansion of the patient population for its new anemia drug Vafseo, the company said.
The proposed trial aimed to study the use of vadadustat to treat anemia in patients with late-stage chronic kidney disease not on dialysis. The treatment is already approved for such patients who have ...
Agios Pharmaceuticals (($AGIO)) announced an update on their ongoing clinical study. Agios Pharmaceuticals is conducting a study titled ‘A Phase ...
Melanoma is the most common form of skin cancer, but for patients with advanced melanoma who no longer respond to standard ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Obstructive sleep apnoea ...
The FDA approved nerandomilast (Jascayd) tablets for idiopathic pulmonary fibrosis (IPF), the first new product for the progressive lung condition in over a decade, the agency announced on Tuesday.
Her treatment plan, including transfusions and medication, has been successful and she has returned ... Doctors diagnosed ...
A newly filed federal lawsuit alleges that a Minnesota postal worker died after police officers and jail staff ignored clear signs he was suffering from a massive stroke - mistaking his medical ...
US officials say they have carried out a number of strikes on boats in the Caribbean Sea, killing multiple drug traffickers. Announcing the first of these in September, President Donald Trump said his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results